New drug combo trial aims to boost fight against aggressive lymphoma
Disease control
Terminated
This study is testing whether adding the drug tazemetostat to standard CHOP chemotherapy works better for people with newly diagnosed T cell lymphoma. About 24 participants will receive the combination treatment, and researchers will measure how well the cancer responds and how l…
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC